Cognito Therapeutics is a clinical-stage neurotechnology company pioneering a non-invasive therapy to slow neurodegeneration and preserve cognitive function in patients with Alzheimer’s disease. The company’s approach, grounded in over 30 years of neuroscience research from MIT, Harvard, and Stanford, uses precise visual and auditory stimulation to engage the brain’s natural rhythms—offering the potential to shift the treatment paradigm for millions of patients worldwide.
Following promising outcomes from Phase 2 trials and an Open Label Extension, Cognito is now nearing completion of enrollment for a pivotal Phase 3 trial, with data expected in summer 2026. The company’s at-home therapy has been granted Breakthrough Device designation by the FDA and is backed by a world-class Scientific and Medical Advisory Board, including Nobel Laureates.
The Challenge
As Cognito entered its next phase of growth, the leadership team began preparing for a $110M Series C fundraising round. With $60M already committed by existing investors, the company sought to broaden its base by engaging new mission-aligned Family Offices.
Unlike institutional capital, Family Office capital often moves through trusted relationships and requires more personalized outreach. Cognito needed a way to identify these decision-makers and engage them efficiently without losing the nuance of its story.
The Solution: Using Family Office Access to Target and Connect
Christian Howell, Chief Executive Officer, and Steve Worthy, Chief Business & Financial Officer, turned to Family Office Access to accelerate this effort. The platform’s database of over 5,000 global Family Offices offered a rich foundation—but it was the strategic support, advanced filters, and intuitive tools that helped the Cognito team take things further.
Through a one-on-one strategy session with our team, Steve explored how to:
- Identify Family Offices that had shown prior interest in healthtech, medical devices, and neuroscience
- Use the Roadmap & Investment Glossary to better understand available filters and refine targeting
- Export lists for customized outreach (available to annual subscribers)
- Submit research requests for highly specific investor profiles
“The Family Office Access platform is robust and incredibly user-friendly. Their many filters and AI-enabled search features help turn an otherwise manual and tedious web-based search process into an intuitive exploration of Family Offices you believe best fit your business’ profile. This, plus the added benefit of getting ongoing support from Danielle and her stellar team, results in the perfect 1-2 punch for anyone looking to systematically access Family Office decision makers.”
— Steve Worthy, Chief Business & Financial Officer, Cognito Therapeutics
“Our goal is to align with partners who not only understand the science, but who believe in supporting bold solutions with long-term impact. Family Office Access is helping us bridge that gap with tools that bring clarity and focus to our investor engagement.”
— Christian Howell, Chief Executive Officer, Cognito Therapeutics
Looking Ahead
As Cognito continues to advance its Phase 3 clinical trial and raise capital for its next chapter, Family Office Access will remain a key resource in their outreach strategy. The combination of high-quality data and human-centered support has helped the Cognito team align with investors who understand both the scientific rigor and mission-driven purpose behind their work.
To learn more about Cognito Therapeutics, visit www.cognitotx.com.